Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Chad_Robins
|
| gptkbp:collaboratedWith |
gptkb:Microsoft
|
| gptkbp:focusesOn |
therapeutics
diagnostics immune repertoire profiling |
| gptkbp:foundedBy |
gptkb:Chad_Robins
gptkb:Harlan_Robins |
| gptkbp:foundedYear |
2009
|
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Adaptive Biotechnologies
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:IPODate |
2019
|
| gptkbp:numberOfEmployees |
over 500
|
| gptkbp:product |
gptkb:T-Detect
gptkb:clonoSEQ gptkb:immunoSEQ |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:specializesIn |
immune-driven medicine
immunosequencing |
| gptkbp:tradedOn |
gptkb:NASDAQ:ADPT
|
| gptkbp:website |
https://www.adaptivebiotech.com/
|
| gptkbp:bfsParent |
gptkb:Casdin_Capital
|
| gptkbp:bfsLayer |
6
|